1.
Mjali A, Obaid M, Matti B, Abbas N. Treatment Outcomes of Nilotinib as Second Line Therapy for Chronic Myeloid Leukemia Patients in Karbala Province of Iraq. apjcc [Internet]. 14Jun.2022 [cited 26Nov.2022];7(2):267-72. Available from: http://waocp.com/journal/index.php/apjcc/article/view/870